XML 135 R66.htm IDEA: XBRL DOCUMENT
v3.23.1

Financial instruments - additional disclosures (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Financial Instruments - additional disclosure [abstract] |
Disclosure of financial assets and financial liabilities |
|  |  |  | 2022 |
(USD millions) |  | Note |  | Financial instruments at amortized costs |  | Financial instruments at fair value through other comprehensive income |  | Financial instruments at fair value through the consolidated income statement |  | Other financial liabilities at amortized costs |
Cash and cash equivalents |  | 16 |  | 7 517 |  |  |  |  |  |  |
Time deposits and short-term investments with original maturity more than 90 days |  | 16 |  | 11 089 |  |  |  |  |  |  |
Trade receivables |  | 15 |  | 8 066 |  |  |  |  |  |  |
Other receivables and current assets |  | 17 |  | 958 |  |  |  |  |  |  |
Marketable securities - debt securities |  | 16 |  |  |  | 9 |  |  |  |  |
Long-term financial investments - equity securities |  | 13 |  |  |  | 828 |  | 317 |  |  |
Long-term financial investments - debt securities |  | 13 |  |  |  | 37 |  |  |  |  |
Long-term financial investments - fund investments |  | 13 |  |  |  |  |  | 281 |  |  |
Long-term loans, advances, security deposits and other long-term receivables |  | 13 |  | 341 |  |  |  |  |  |  |
Associated companies at fair value through profit and loss |  |  |  |  |  |  |  | 129 |  |  |
Derivative financial instruments |  | 16 |  |  |  |  |  | 204 |  |  |
Contingent consideration receivables |  | 13/17 |  |  |  |  |  | 650 |  |  |
Total financial assets |  |  |  | 27 971 |  | 874 |  | 1 581 |  |  |
Bank and other short-term financial debt |  | 21 |  | 863 |  |  |  |  |  |  |
Commercial paper |  | 21 |  | 2 772 |  |  |  |  |  |  |
Straight bonds |  | 19 |  | 22 341 |  |  |  |  |  |  |
Long-term liabilities to banks and other financial institutions |  | 19 |  | 144 |  |  |  |  |  |  |
Trade payables |  |  |  | 5 146 |  |  |  |  |  |  |
Contingent consideration liabilities (see Note 20/22) and other financial liabilities |  |  |  |  |  |  |  | 1 067 |  |  |
Derivative financial instruments |  | 21 |  |  |  |  |  | 55 |  |  |
Lease liabilities |  | 10 |  |  |  |  |  |  |  | 1 789 |
Total financial liabilities |  |  |  | 31 266 |  |  |  | 1 122 |  | 1 789 |
|  |  |  | 2021 |
(USD millions) |  | Note |  | Financial instruments at amortized costs |  | Financial instruments at fair value through other comprehensive income |  | Financial instruments at fair value through the consolidated income statement |  | Other financial liabilities at amortized costs |
Cash and cash equivalents 1 |  | 16 |  | 10 397 |  | 2 010 |  |  |  |  |
Time deposits and short-term investments with original maturity more than 90 days |  | 16 |  | 12 965 |  |  |  |  |  |  |
Trade receivables |  | 15 |  | 8 005 |  |  |  |  |  |  |
Other receivables and current assets |  | 17 |  | 793 |  |  |  |  |  |  |
Marketable securities - debt securities |  | 16 |  |  |  | 2 741 |  |  |  |  |
Long-term financial investments - equity securities |  | 13 |  |  |  | 1 195 |  | 468 |  |  |
Long-term financial investments - debt securities |  | 13 |  |  |  | 34 |  |  |  |  |
Long-term financial investments - fund investments |  | 13 |  |  |  |  |  | 366 |  |  |
Long-term loans, advances, security deposits and other long-term receivables |  | 13 |  | 332 |  |  |  |  |  |  |
Associated companies at fair value through profit and loss |  |  |  |  |  |  |  | 192 |  |  |
Derivative financial instruments |  | 16 |  |  |  |  |  | 105 |  |  |
Contingent consideration receivables |  | 13 |  |  |  |  |  | 641 |  |  |
Total financial assets |  |  |  | 32 492 |  | 5 980 |  | 1 772 |  |  |
Interest-bearing accounts of employees payable on demand |  | 21 |  | 1 814 |  |  |  |  |  |  |
Bank and other short-term financial debt |  | 21 |  | 899 |  |  |  |  |  |  |
Commercial paper |  | 21 |  | 893 |  |  |  |  |  |  |
Straight bonds |  | 19 |  | 25 296 |  |  |  |  |  |  |
Long-term liabilities to banks and other financial institutions |  | 19 |  | 227 |  |  |  |  |  |  |
Trade payables |  |  |  | 5 553 |  |  |  |  |  |  |
Commitment for repurchase of own shares |  | 18/22 |  | 2 809 |  |  |  |  |  |  |
Contingent consideration liabilities (see Note 20/22) and other financial liabilities |  |  |  |  |  |  |  | 1 094 |  |  |
Derivative financial instruments |  | 21 |  |  |  |  |  | 68 |  |  |
Lease liabilities |  | 10 |  |  |  |  |  |  |  | 1 896 |
Total financial liabilities |  |  |  | 37 491 |  |  |  | 1 162 |  | 1 896 |
1 Includes short-term highly rated government-backed debt securities, with an original maturity of three months or less
Derivative financial instruments |
|  | Contract or underlying principal amount |  | Positive fair values |  | Negative fair values |
(USD millions) |  | 2022 |  | 2021 |  | 2022 |  | 2021 |  | 2022 |  | 2021 |
Forward foreign exchange rate contracts |  | 7 907 |  | 13 248 |  | 189 |  | 92 |  | -41 |  | -35 |
Commodity purchase contract |  | 97 |  | 17 |  | 15 |  | 13 |  |  |  |  |
Options on equity securities |  | 39 |  | 82 |  |  |  |  |  | -14 |  | -33 |
Total derivative financial instruments included in marketable securities and in current financial debts |  | 8 043 |  | 13 347 |  | 204 |  | 105 |  | -55 |  | -68 |
Contract or underlying principal amount the derivative financial instruments, by currency |
|  | 2022 |
(USD millions) |  | EUR |  | USD |  | Other |  | Total |
Forward foreign exchange rate contracts |  | 687 |  | 5 659 |  | 1 561 |  | 7 907 |
Commodity purchase contract |  | 80 |  | 17 |  |  |  | 97 |
Options on equity securities |  |  |  | 39 |  |  |  | 39 |
Total derivative financial instruments |  | 767 |  | 5 715 |  | 1 561 |  | 8 043 |
|  | 2021 |
(USD millions) |  | EUR |  | USD |  | Other |  | Total |
Forward foreign exchange rate contracts |  | 1 485 |  | 5 158 |  | 6 605 |  | 13 248 |
Commodity purchase contract |  |  |  | 17 |  |  |  | 17 |
Options on equity securities |  |  |  | 82 |  |  |  | 82 |
Total derivative financial instruments |  | 1 485 |  | 5 257 |  | 6 605 |  | 13 347 |
Fair value by hierarchy |
|  | 2022 |
(USD millions) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |
Financial assets |  |  |  |  |  |  |  |  |
Marketable securities |  |  |  |  |  |  |  |  |
Debt securities |  |  |  | 9 |  |  |  | 9 |
Derivative financial instruments |  |  |  | 204 |  |  |  | 204 |
Total marketable securities and derivative financial instruments at fair value |  |  |  | 213 |  |  |  | 213 |
Current contingent consideration receivables |  |  |  |  |  | 43 |  | 43 |
Long-term financial investments |  |  |  |  |  |  |  |  |
Debt and equity securities |  | 473 |  | 10 |  | 699 |  | 1 182 |
Fund investments |  | 20 |  |  |  | 261 |  | 281 |
Non-current contingent consideration receivables |  |  |  |  |  | 607 |  | 607 |
Total long-term financial investments at fair value |  | 493 |  | 10 |  | 1 567 |  | 2 070 |
Associated companies at fair value through profit and loss |  |  |  |  |  | 129 |  | 129 |
Financial liabilities |  |  |  |  |  |  |  |  |
Current contingent consideration liabilities |  |  |  |  |  | -131 |  | -131 |
Derivative financial instruments |  |  |  | -55 |  |  |  | -55 |
Total current financial liabilities at fair values |  |  |  | -55 |  | -131 |  | -186 |
Non-current contingent consideration liabilities |  |  |  |  |  | -704 |  | -704 |
Other financial liabilities |  |  |  |  |  | -232 |  | -232 |
Total non-current financial liabilities at fair value |  |  |  |  |  | -936 |  | -936 |
|  | 2021 |
(USD millions) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |
Financial assets |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  |  |  |  |  |  |  |  |
Debt securities 1 |  | 2 010 |  |  |  |  |  | 2 010 |
Total cash and cash equivalents at fair value |  | 2 010 |  |  |  |  |  | 2 010 |
Marketable securities and derivative financial instruments |  |  |  |  |  |  |  |  |
Debt securities |  | 2 719 |  | 22 |  |  |  | 2 741 |
Derivative financial instruments |  |  |  | 105 |  |  |  | 105 |
Total marketable securities and derivative financial instruments at fair value |  | 2 719 |  | 127 |  |  |  | 2 846 |
Long-term financial investments |  |  |  |  |  |  |  |  |
Debt and equity securities |  | 1 080 |  |  |  | 617 |  | 1 697 |
Fund investments |  | 28 |  |  |  | 338 |  | 366 |
Contingent consideration receivables |  |  |  |  |  | 641 |  | 641 |
Total long-term financial investments at fair value |  | 1 108 |  |  |  | 1 596 |  | 2 704 |
Associated companies at fair value through profit and loss |  |  |  |  |  | 192 |  | 192 |
Financial liabilities |  |  |  |  |  |  |  |  |
Contingent consideration payables |  |  |  |  |  | -1 075 |  | -1 075 |
Derivative financial instruments |  |  |  | -68 |  |  |  | -68 |
Other financial liabilities |  |  |  |  |  | -19 |  | -19 |
Total financial liabilities at fair value |  |  |  | -68 |  | -1 094 |  | -1 162 |
1 Includes short-term highly rated government-backed debt securities, with an original maturity of three months or less
Reconciliation of changes in fair value measurement |
|  | 2022 |
(USD millions) |  | Associated companies at fair value through profit and loss |  | Fund investments |  | Long-term financial investments |  | Contingent consideration receivables |  | Contingent consideration liabilities |  | Other financial liabiltiies |
January 1 |  | 192 |  | 338 |  | 617 |  | 641 |  | -1 075 |  | -19 |
Fair value gains and other adjustments, including from divestments recognized in the consolidated income statement |  |  |  | 4 |  | 35 |  | 53 |  | 530 |  | 15 |
Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement |  | -63 |  | -78 |  | -84 |  |  |  | -114 |  | -18 |
Fair value adjustments recognized in the consolidated statement of comprehensive income, including currency translation effects |  |  |  |  |  | 24 |  |  |  | 11 |  |  |
Purchases |  | 4 |  | 11 |  | 160 |  |  |  | -231 |  | -238 |
Cash receipts and payments |  |  |  |  |  |  |  | -44 |  | 44 |  | 28 |
Disposals |  |  |  | -12 |  | -13 |  |  |  |  |  |  |
Reclassification |  | -4 |  | -2 |  | -40 |  |  |  |  |  |  |
December 31 |  | 129 |  | 261 |  | 699 |  | 650 |  | -835 |  | -232 |
Total of fair value gains and losses recognized in the consolidated income statement for assets and liabilities held at December 31, 2022 |  | -63 |  | -74 |  | -49 |  | 53 |  | 416 |  | -3 |
|  | 2021 |
(USD millions) |  | Associated companies at fair value through profit and loss |  | Fund investments |  | Long-term financial investments |  | Contingent consideration receivables |  | Contingent consideration payables |
January 1 |  | 211 |  | 366 |  | 460 |  | 625 |  | -1 046 |
Fair value gains and other adjustments, including from divestments recognized in the consolidated income statement |  | 2 |  | 70 |  | 69 |  | 124 |  | 182 |
Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement |  | -26 |  | -8 |  | -13 |  | -44 |  | -189 |
Fair value adjustments recognized in the consolidated statement of comprehensive income, including currency translation effects |  | -2 |  | -1 |  | 51 |  | -22 |  | 22 |
Purchases |  | 34 |  | 12 |  | 137 |  |  |  | -88 |
Cash receipts and payments |  |  |  |  |  |  |  | -42 |  | 44 |
Disposals |  | -27 |  | -71 |  | -43 |  |  |  |  |
Reclassification |  |  |  | -30 |  | -44 |  |  |  |  |
December 31 |  | 192 |  | 338 |  | 617 |  | 641 |  | -1 075 |
Total of fair value gains and losses recognized in the consolidated income statement for assets and liabilities held at December 31, 2021 |  | -24 |  | 62 |  | 56 |  | 80 |  | -7 |
Equity securities measured at fair value through other comprehensive income |
(USD millions) |  | 2022 |  | 2021 |
Listed equity securities |  | 438 |  | 888 |
Non-listed equity securities |  | 390 |  | 307 |
Total equity securities |  | 828 |  | 1 195 |
Monitoring of net debt or liquidity based on contractual maturities |
|  | 2022 |
(USD millions) |  | Due within one month |  | Due later than one month but less than three months |  | Due later than three months but less than one year |  | Due later than one year but less than five years |  | Due after five years |  | Total |
Current assets |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable securities, time deposits and short-term investments with original maturity more than 90 days and accrued interest |  | 4 142 |  | 6 911 |  | 36 |  |  |  | 9 |  | 11 098 |
Commodities |  |  |  |  |  |  |  |  |  | 111 |  | 111 |
Derivative financial instruments |  | 23 |  | 147 |  | 19 |  |  |  | 15 |  | 204 |
Cash and cash equivalents |  | 4 011 |  | 3 506 |  |  |  |  |  |  |  | 7 517 |
Total current financial assets |  | 8 176 |  | 10 564 |  | 55 |  |  |  | 135 |  | 18 930 |
Non-current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Financial debt |  |  |  |  |  |  |  | -8 975 |  | -11 269 |  | -20 244 |
Financial debt - undiscounted |  |  |  |  |  |  |  | -9 002 |  | -11 394 |  | -20 396 |
Total non-current financial debt |  |  |  |  |  |  |  | -8 975 |  | -11 269 |  | -20 244 |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Financial debt |  | -3 215 |  | -146 |  | -2 515 |  |  |  |  |  | -5 876 |
Financial debt - undiscounted |  | -3 215 |  | -146 |  | -2 517 |  |  |  |  |  | -5 878 |
Derivative financial instruments |  | -38 |  | -13 |  | -4 |  |  |  |  |  | -55 |
Total current financial debt |  | -3 253 |  | -159 |  | -2 519 |  |  |  |  |  | -5 931 |
Net debt |  | 4 923 |  | 10 405 |  | -2 464 |  | -8 975 |  | -11 134 |  | -7 245 |
|  | 2021 |
(USD millions) |  | Due within one month |  | Due later than one month but less than three months |  | Due later than three months but less than one year |  | Due later than one year but less than five years |  | Due after five years |  | Total |
Current assets |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable securities, time deposits and short-term investments with original maturity more than 90 days and accrued interest |  | 11 |  | 14 585 |  | 1 088 |  | 4 |  | 18 |  | 15 706 |
Commodities |  |  |  |  |  |  |  |  |  | 111 |  | 111 |
Derivative financial instruments |  | 21 |  | 64 |  | 7 |  |  |  | 13 |  | 105 |
Cash and cash equivalents |  | 7 406 |  | 5 001 |  |  |  |  |  |  |  | 12 407 |
Total current financial assets |  | 7 438 |  | 19 650 |  | 1 095 |  | 4 |  | 142 |  | 28 329 |
Non-current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Financial debt |  |  |  |  |  |  |  | -8 464 |  | -14 438 |  | -22 902 |
Financial debt - undiscounted |  |  |  |  |  |  |  | -8 490 |  | -14 587 |  | -23 077 |
Total non-current financial debt |  |  |  |  |  |  |  | -8 464 |  | -14 438 |  | -22 902 |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |  |
Financial debt |  | -2 780 |  | -521 |  | -2 926 |  |  |  |  |  | -6 227 |
Financial debt - undiscounted |  | -2 780 |  | -521 |  | -2 928 |  |  |  |  |  | -6 229 |
Derivative financial instruments |  | -50 |  | -16 |  | -2 |  |  |  |  |  | -68 |
Total current financial debt |  | -2 830 |  | -537 |  | -2 928 |  |  |  |  |  | -6 295 |
Net debt |  | 4 608 |  | 19 113 |  | -1 833 |  | -8 460 |  | -14 296 |  | -868 |
Derivative financial instruments and accrued interest on derivative financial instruments |
|  | 2022 |
(USD millions) |  | Due within one month |  | Due later than one month but less than three months |  | Due later than three months but less than one year |  | Total |
Derivative financial instruments and accrued interest on derivative financial instruments |  |  |  |  |  |  |  |  |
Potential outflows in various currencies - from financial derivative liabilities |  | -2 029 |  | -4 598 |  | -316 |  | -6 943 |
Potential inflows in various currencies - from financial derivative assets |  | 2 029 |  | 4 712 |  | 321 |  | 7 062 |
|  | 2021 |
(USD millions) |  | Due within one month |  | Due later than one month but less than three months |  | Due later than three months but less than one year |  | Total |
Derivative financial instruments and accrued interest on derivative financial instruments |  |  |  |  |  |  |  |  |
Potential outflows in various currencies - from financial derivative liabilities |  | -843 |  | -5 482 |  | -461 |  | -6 786 |
Potential inflows in various currencies - from financial derivative assets |  | 847 |  | 5 516 |  | 457 |  | 6 820 |
Other contractual liabilities of the net debt or liquidity |
|  | 2022 |
(USD millions) |  | Due within three months |  | Due later than three months but less than one year |  | Due later than one year but less than five years |  | Due after five years |  | Total |
Contractual interest on non-current liabilities |  | -64 |  | -412 |  | -1 432 |  | -3 624 |  | -5 532 |
Lease liabilities 1 |  | -71 |  | -180 |  | -616 |  | -922 |  | -1 789 |
Trade payables |  | -5 020 |  | -126 |  |  |  |  |  | -5 146 |
Contingent consideration liabilities |  | -16 |  | -115 |  | -437 |  | -267 |  | -835 |
1 Note 10 provides additional disclosures related to lease liabilities.
|  | 2021 |
(USD millions) |  | Due within three months |  | Due later than three months but less than one year |  | Due later than one year but less than five years |  | Due after five years |  | Total |
Contractual interest on non-current liabilities |  | -82 |  | -445 |  | -1 628 |  | -3 908 |  | -6 063 |
Lease liabilities 1 |  | -78 |  | -197 |  | -639 |  | -982 |  | -1 896 |
Trade payables |  | -5 373 |  | -180 |  |  |  |  |  | -5 553 |
Commitment for repurchase of own shares |  | -2 809 |  |  |  |  |  |  |  | -2 809 |
Contingent consideration liabilities |  | -54 |  | -65 |  | -517 |  | -439 |  | -1 075 |
1 Note 10 provides additional disclosures related to lease liabilities.
Potential impact on the consolidated income statement due to increase (decrease) in currency exchange rates |
(USD millions) |  | 2022 |  | 2021 |
5% increase in foreign currency exchange rates against USD |  | -6 |  | 3 |
5% decrease in foreign currency exchange rates against USD |  | 7 |  | -3 |
Potential impact on the consolidated equity due to increase (decrease) in currency exchange rates |
(USD millions) |  | 2022 |  | 2021 |
5% increase in foreign currency exchange rates against USD |  | 93 |  | 99 |
5% decrease in foreign currency exchange rates against USD |  | -98 |  | -104 |
Potential impact on the consolidated income statement due to increase (decrease) in equity prices |
(USD millions) |  | 2022 |  | 2021 |
15% increase in equity prices |  | 109 |  | 154 |
15% decrease in equity prices |  | -109 |  | -154 |
Potential impact on the consolidated equity due to increase (decrease) in equity prices |
(USD millions) |  | 2022 |  | 2021 |
15% increase in equity prices |  | 124 |  | 179 |
15% decrease in equity prices |  | -124 |  | -179 |

X
- Definition The disclosure of derivative financial instruments. [Refer: Derivatives [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for fair value measurement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2022-03-24 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS13_g91-99__IFRS13_g91-99_TI -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfFairValueMeasurementExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the fair value of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: Investments in equity instruments designated at fair value through other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2022-03-24 -Paragraph 11A -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_11A_c&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_FinancialInstrumentsAdditionalDisclosureAbstract
Namespace Prefix: | nvs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_PotentialImpactOnTheConsolidatedIncomeStatementDueToIncreaseDecreaseInCurrencyExchangeRatesTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_PotentialImpactOnTheConsolidatedIncomeStatementDueToIncreaseDecreaseInEquityPricesTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_PotentialImpactOnTheConsolidatedequityDueToIncreaseDecreaseInCurrencyExchangeRatesTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_PotentialImpactOnTheConsolidatedequityDueToIncreaseDecreaseInEquityPricesTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration